{"id":71986,"date":"2025-06-23T07:23:50","date_gmt":"2025-06-23T07:23:50","guid":{"rendered":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/?p=71986"},"modified":"2025-06-23T07:29:23","modified_gmt":"2025-06-23T07:29:23","slug":"peru-welcomes-us-once-again-enzyme-blend-innovations-and-disruptive-new-launches-by-it-pharma","status":"publish","type":"post","link":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/?p=71986&lang=en","title":{"rendered":"Peru welcomes us once again: enzyme blend innovations and disruptive new launches by IT Pharma"},"content":{"rendered":"

Two years after our first visit, IT Pharma returned to Lima to participate in <\/span><\/b>The Faces<\/span><\/i><\/b>, one of the most important aesthetic medicine congresses in Latin America. This time, the company brought specialized training led by Dr. Luc\u00eda Ferraz, along with groundbreaking innovations shaping the future of the industry.<\/span><\/b>\u00a0<\/span><\/p>\n

Back in 2022, IT Pharma made its debut in Peru with the launch of the Inbiotec and Essentials lines<\/strong>, marking the beginning of a solid relationship with the local market. On June 7th, IT Pharma returned to Lima to take part in <\/span>The Faces<\/i><\/strong>, a key event<\/strong> on the Latin American aesthetic medicine calendar.<\/span>\u00a0<\/span><\/p>\n

The visit was led by \u00c1lvaro L\u00f3pez, Chief Commercial Officer at IT Pharma,<\/strong> who joined the event as part of the brand\u2019s Latin American expansion strategy and to support the educational team. Within this framework, the renowned Dr. Luc\u00eda Ferraz conducted a theoretical-practical workshop<\/strong> on the use of Enzyme Blend, designed for aesthetic physicians interested in advanced techniques and customized treatment protocols. The session drew significant interest thanks to its innovative approach and practical experience.<\/span>\u00a0<\/span><\/p>\n

In addition to the workshop, the event showcased cutting-edge developments<\/strong> in regenerative aesthetic medicine\u2014among them, two highly anticipated IT Pharma products: <\/span>Inbiotec Amber<\/span><\/b> and<\/strong> <\/span>NXO<\/span><\/b>. Inbiotec Amber stood out for its <\/span>skin-building action<\/span><\/i>, powered by non-crosslinked hyaluronic acid and succinic acid, while NXO, featuring a novel formulation based on exosomal nanovesicles, was highlighted for its potential to redefine next-generation regenerative treatments.<\/span>\u00a0<\/span><\/p>\n

With its presence at <\/span>The Faces<\/span><\/i>, IT Pharma reaffirms its commitment to scientific development, continuous professional education, and the building of strong relationships across Latin America. Peru remains a strategic market, home to a medical community that is both innovation-driven and technically rigorous.<\/span>\u00a0<\/span><\/p>\n

Thank you, Peru, for welcoming us once again with such enthusiasm!<\/span><\/b>\u00a0<\/span><\/p>\n

\"sin<\/p>\n

\"sin<\/p>\n","protected":false},"excerpt":{"rendered":"

Two years after our first visit, IT Pharma returned to Lima to participate in The Faces, one of the most important aesthetic medicine congresses in Latin America. This time, the company brought specialized training led by Dr. Luc\u00eda Ferraz, along with groundbreaking innovations shaping the future of the industry.\u00a0 Back in 2022, IT Pharma made […]<\/p>\n","protected":false},"author":94,"featured_media":71991,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[877],"tags":[],"class_list":{"0":"post-71986","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sin-categoria-en"},"_links":{"self":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/71986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/users\/94"}],"replies":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=71986"}],"version-history":[{"count":6,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/71986\/revisions"}],"predecessor-version":[{"id":71999,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/71986\/revisions\/71999"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=\/wp\/v2\/media\/71991"}],"wp:attachment":[{"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=71986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=71986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fervent-dubinsky.82-165-171-139.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=71986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}